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ABSTRACT 
A stability indicating method has been developed for specific determination of Metoclopramide HCl in bulk by UV spectrophotometry in presence of 
its degradation products. The method is simple, accurate, precise, and robust. Linearity range for the method is 10-50µg/ml at detection wavelength 
of 272 nm. The LOD and LOQ values were found to be 3.26µg/ml and 9.89µg/ml respectively. 




2-methoxybenzamide hydrochloride, is an antiemetic drug. It 
inhibits gastric smooth muscle relaxation produced by dopamine 
and therefore increases cholinergic response of gastrointestinal 
tract. [1,2]  
Knowledge of the stability of the molecule helps in selecting proper 
formulation and package as well as providing proper storage 
conditions and shelf life, which is essential for regulatory 
documentation. Forced degradation is a process that involves 
degradation of drug products and drug substances at conditions 
more severe than accelerated conditions and thus generates 
degradation products that can be studied to determine the stability 
of the molecule [3]. The presently available literature reveals few 
analytical methods for determination of Metoclopramide HCl by 
HPLC [4,5], UV spectrophotometry [6,7], LC-MS [8], in plasma [9].  
The objective of this work was to develop a validated Stability 
indicating assay method for the determination of Metoclopramide 
hydrochloride in presence of its degradation products generated by 
subjecting the drug to forced degradation conditions under acid, 
alkali, thermal and oxidative stress as per the guidelines[10] and to 
establish the inherent stability of Metoclopramide hydrochloride. 
MATERIALS AND METHODS 
Metoclopramide hydrochloride was supplied by IPCA Laboratories, 
Aurangabad as the gift sample. Its identity and purity were 
confirmed by recording the FTIR spectra. Solvent used was 
Deionized water from the water treatment plant (SG) of the 
Institute. The reagents used were Hydrochloric acid (Qualigens), 
Sodium hydroxide & Hydrogen Peroxide 50% solution. 
Apparatus  
UV Spectrophotometer- Shimadzu Japan UV 1700, FT-IR- Thermo 




Spectrophotometric analysis was carried out at ambient 
temperature. Solvent used was deionized water; standard solution 
of 50µg/ml was analyzed at 272 nm. 
Preparation of stock and standard solution 
Accurately weighed 100mg of standard Metoclopramide HCl was 
transferred to 100 ml volumetric flask to make a stock solution of 
1000µg/ml. Suitable aliquots were taken into 100 ml volumetric 
flask to make standard solutions in the range of 10-50 µg/ml.  
Preparation of calibration curve 
The calibration curve was prepared in the concentration range 10-
50μg/ml by analyzing each solution in triplicate and plotting the 
concentration (μg/ml) against absorbance. The correlation 
coefficient and equation of the line were determined. The spectrum 
of fresh drug solution (50µg/ml) is shown in fig1 and the calibration 
curve in fig 2. The data is shown in table 2. 
Forced degradation studies  
The forced degradation of MTD was done in each of the stress 
condition at a concentration of 1 mg/ml. The degradation was 
confirmed in each case by recording the changes in the ultraviolet 
spectra of each stressed sample comparing it with that of fresh drug 
solution.  
A. Acidic stress  
100 mg of MTD was refluxed in 1 N Hydrochloric acid for 4 hours in 
a water bath at 70o
B. Alkaline stress  
C.  
100 mg of MTD was refluxed in 1 N sodium hydroxide for 4 hours in 
a water bath at 70o
C. Thermal stress  
C.  
100 mg of MTD was kept in solid state at 70o
D. Oxidative stress  
C for 4 hours in an oven 
equipped with temperature control probe.  
100 mg of MTD was dissolved in 3% and 6% Hydrogen peroxide 
separately and kept at room temperature for 24 hours in amber 
colored stoppered vials. 
RESULTS AND DISCUSSION 
Recording of spectrum of standard solution 
The spectrum of standard drug was recorded with 50µg/ml solution, 
and scanned in the range of 400-200 nm. 272 nm was found to be 
the suitable wavelength for analysis. 
Degradation behavior of MTD  
The amount (percent) of MTD remaining undegraded under each 
stress condition was determined from the absorbance of the fresh 
drug sample relative to that of stressed drug sample. The results are 
shown in table 7. 
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A. Accuracy  
Accuracy of the method was evaluated by spiking the drug at three 
concentration levels (8, 10 & 12µg/ml) to the original 10 µg/ml 
solution. The percent recovery of the added drug was calculated 
from the linearity plots. The results are shown in table 1.  
B. Linearity and range  
The linearity of the method was established by preparing a 
calibration curve in water in the range 10-50μg/ml. Triplicates of 
each of the solution were analyzed and calibration curve recorded. 
The mean (n=3) absorbance was plotted against concentration 
(μg/ml). The correlation coefficient and equation of line were 
determined. The results are shown in fig2 and table 2.  
C. Precision  
The Interday and intraday precision was determined by calculation 
of the % RSD values on triplicates of each concentration. The mean 
(n=3) absorbance of each concentration was compared with that of 
the second run on the same day (intraday) and with that on the next 
day (interday) and the percent relative deviation calculated. The 
results are shown in table 3.  
D. Specificity  
The Specificity of the method was established through the 
determination of the drug in the presence of its degradation 
products with high degree of precision. The spectrum homogeneity 
was confirmed by analyzing the ratio chromatograms at the 
wavelengths 271 nm and 273 nm.  
E. Ruggedness [16] 
Mean absorbance (n=3) was measured for the 10μg/ml solution 
analyzed by two different analysts on different days and the percent 
relative deviation between two trials was calculated. The results are 
shown in table 4.  
 
 




Fig. 2: Calibration curve of Std MTD 
 
F. Robustness  
Deliberate changes in the detection wavelength were made. Three 
replicates of each deviation were analyzed and the %RSD between 
the mean (n=3) absorbance and that obtained under optimized 
spectrophotometric conditions were determined. The results are 
shown in table 5.  
G. Limit of detection and limit of quantitation  
The limit of detection and limit of Quantitation was calculated based 
on standard deviation (σ) and the slope (S) of the calibration plot, 
using the formulae LOD= 3.3σ/s and LOQ=10σ/S as defined by ICH. 
The LOD was found to be 3.26µg/ml and LOQ 9.89µg/ml. 
  
 
Fig. 3: Spectrum of Acid degraded MTD 
 
 
Fig. 4: Spectrum of base degraded MTD 
 
 
Fig. 5: Spectrum of oxidatively (0.3%) degraded MTD 
 
 
Fig. 6: Spectrum of Oxidatively (0.6%) degraded MTD 
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Fig. 7: Spectrum of thermally Degraded MTD  
 
H. System suitability  
The system suitability parameters Linearity and range, accuracy, 
precision and specificity were determined and are shown in table 6. 


















80 17.92 99.55 0.435 
100 20.02 100.1 0.698 
120 22.03 100.13 0.333 
Average %RSD 0.488 
 









1 10 0.498±0.0032 0.642 
2 20 0.883±0.001 0.113 
3 30 1.269±0.0015 0.118 
4 40 1.648±0.0005 0.030 
5 50 2.045±0.0005 0.024 
 
Table 3: Results of Intra-day and Inter-day precision studies 
Drug Intra-day Precision  Inter-day Precision 
Conc. Mean±S. D. %RSD  Mean±S. D. %RSD 
MTD 
 
10 9.99±0.036 0.360  10.005±0.028 0.279 
20 19.91±0.035 0.175  19.98±0.077 0.385 
30 30.02±0.015 0.050  29.97±0.063 0.210 
40 40.07±0.056 0.139  39.96±0.148 0.370 
50 49.70±0.045 0.092  49.84±0.197 0.395 
 Average %RSD  0.163  Average %RSD 0.327 
 
Table 4: Results of ruggedness studies 
Drug 
 
Amount Taken  
(µg/ml)  
Analyst I Analyst II 
Amount Found %RSD Amount Found %RSD 
MTD 10 9.96±0.025 0.25 9.99±0.0152 0.152 
MTD 10  Instrument I  Instrument II 
10.01±0.047 0.47 9.80±0.045 0.459 
 
Table 5: Results of Robustness studies 
Drug Amount Taken 
(µg/ml)  
WL-1 (271 nm) 
Amount %RSD Found  
WL-2 (272 nm) 
Amount %RSD Found 
WL-3 (273 nm) 
Amount %RSD Found 
MTD 10 9.88±0.02 0.202 9.96±0.025 0.25 9.99±0.045 0.45 
 
Table 6: System suitability parameters 
Validation Parameter Values 
Range 10-50µg/ml 
Linearity-  
Regression equation (y=mx+C) y = 0.038x + 0.110 
and Correlation coefficient r r² = 0.9998 2 
LOD 3.26µg/ml 
LOQ 9.89µg/ml 
Recovery (% RSD) 0.488 
Intra-Day Precision 0.163 




Table 7: % Drug Degraded under each stress condition 
S. No. Stress Condition Absorbance % Drug degraded % Drug Remain 
 1 Fresh Solution 2.045 0 100 
2 Acidic 1.927 5.78 94.22 
3 Basic 1.859 9.10 90.90 
4 Oxidative (0.3%) 0.290 85.82 14.18 
5 Oxidative (0.6%) 0.262 87.19 12.81 
6 Thermal 1.639 19.86 80.14 
Gorde et al. 





A validated stability indicating assay method has been developed for 
the determination of Metoclopramide hydrochloride in bulk. The 
results show that the developed method was accurate, precise, 
simple, economic, fast and specific. Metoclopramide HCl is most 
prone to degradation under oxidative (6%) stress, followed in order 
by the stress oxidative (3%), thermal, basic, and acidic.  
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